X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1460) 1460
Publication (114) 114
Government Document (29) 29
Dissertation (27) 27
Book Chapter (14) 14
Book Review (13) 13
Conference Proceeding (10) 10
Magazine Article (3) 3
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
her2/neu (982) 982
humans (953) 953
female (722) 722
oncology (649) 649
breast cancer (581) 581
index medicus (441) 441
receptor, erbb-2 - metabolism (345) 345
cancer (327) 327
trastuzumab (313) 313
middle aged (311) 311
immunohistochemistry (304) 304
breast neoplasms - pathology (286) 286
animals (271) 271
aged (261) 261
her2 (259) 259
expression (254) 254
adult (242) 242
receptor, erbb-2 - genetics (240) 240
breast neoplasms - metabolism (228) 228
mice (210) 210
neu (204) 204
prognosis (203) 203
breast neoplasms - drug therapy (182) 182
carcinoma (180) 180
monoclonal-antibody (178) 178
cell line, tumor (176) 176
breast neoplasms - genetics (171) 171
chemotherapy (159) 159
pathology (159) 159
overexpression (158) 158
her2/neu-overexpressing metastatic breast (156) 156
male (154) 154
antibodies, monoclonal, humanized (149) 149
breast-cancer (146) 146
her-2/neu (144) 144
aged, 80 and over (137) 137
therapy (137) 137
receptor, erbb-2 - immunology (136) 136
gene amplification (135) 135
antineoplastic agents - therapeutic use (126) 126
research (125) 125
tumors (124) 124
amplification (119) 119
ovarian-cancer (118) 118
immunology (116) 116
in-situ hybridization (116) 116
biochemistry & molecular biology (113) 113
cell biology (112) 112
antibodies, monoclonal - therapeutic use (109) 109
receptor, erbb-2 - analysis (108) 108
skin and connective tissue diseases (107) 107
apoptosis (106) 106
phase-ii (106) 106
immunotherapy (105) 105
tumor cells, cultured (105) 105
medicine & public health (103) 103
survival (103) 103
receptor, erbb-2 - biosynthesis (102) 102
genes, erbb-2 (99) 99
cells (98) 98
care and treatment (96) 96
proteins (96) 96
in situ hybridization, fluorescence (94) 94
neoplasm staging (94) 94
analysis (93) 93
gene expression regulation, neoplastic (93) 93
metastasis (92) 92
oncogene (90) 90
growth-factor receptor (89) 89
neu oncogene (87) 87
genetic aspects (86) 86
antineoplastic agents - pharmacology (85) 85
receptor (85) 85
breast neoplasms - therapy (84) 84
gene expression (84) 84
protein (82) 82
medicine, research & experimental (81) 81
health aspects (80) 80
epidermal growth factor (76) 76
erbb2 (74) 74
retrospective studies (74) 74
neoplasms (73) 73
pharmacology & pharmacy (72) 72
in-vivo (71) 71
treatment outcome (69) 69
dendritic cells (68) 68
growth (68) 68
article (66) 66
biomarkers, tumor - analysis (66) 66
receptor, erbb-2 - antagonists & inhibitors (66) 66
breast neoplasms - immunology (64) 64
p53 (63) 63
genetics & heredity (62) 62
c-erbb-2 (61) 61
biomarkers, tumor - metabolism (60) 60
signal transduction (60) 60
surgery (60) 60
erbb-2 protein (59) 59
development and progression (58) 58
estrogen (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1465) 1465
Chinese (23) 23
Spanish (16) 16
French (11) 11
German (9) 9
Japanese (8) 8
Polish (5) 5
Russian (5) 5
Korean (3) 3
Bosnian (1) 1
Hungarian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Zanco Journal of Medical Sciences, ISSN 1995-5588, 12/2019, Volume 23, Issue 3, pp. 421 - 428
Background and objective: Colorectal carcinoma is one of the commonest cancers and the second leading cause of cancer death in Europe and North America.... 
immunoexpression | her2/neu | colorectal carcinoma
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 11/2013, Volume 171, Issue 3, pp. 322 - 329
Journal Article
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 06/2009, Volume 50, Issue 6, pp. 974 - 981
The anti-human epidermal growth factor receptor 2 (HER2/neu) antibody trastuzumab is administered to patients with HER2/neu-overexpressing breast cancer.... 
TARGET | PROTEIN | TRASTUZUMAB | C-ERBB2 | BEARING NUDE-MICE | breast cancer | HER2/neu | imaging | immunoPET | THERAPY | BREAST-CANCER XENOGRAFTS | MONOCLONAL-ANTIBODIES | PET | ANTIGEN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 02/2020, Volume 24, p. 102150
Myeloid-derived suppressor cells (MDSCs) play a pivotal role in cancer. To overcome the problem of the MDSCs in the tumor microenvironment in this study, a... 
Liposomal HER2/neu-derived peptide | Doxil | Breast cancer | MDSC | Chemoimmunotherapy
Journal Article
NUCLEAR MEDICINE AND BIOLOGY, ISSN 0969-8051, 01/2013, Volume 40, Issue 1, pp. 3 - 14
The advent of antibody-based cancer therapeutics has led to the concomitant rise in the development of companion diagnostics for these therapies, particularly... 
ImmunoPET | IMMUNO-PET | HER2/NEU EXPRESSION | Antibody | BEARING NUDE-MICE | ZIRCONIUM COMPLEXES | P-ISOTHIOCYANATOBENZYL-DESFERRIOXAMINE | POSITRON-EMISSION-TOMOGRAPHY | BIFUNCTIONAL CHELATE | Radiochemistry | IN-VIVO | GROWTH-FACTOR | PET Imaging | MONOCLONAL-ANTIBODIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Zr-89
Journal Article
Acta Naturae, ISSN 2075-8251, 2015, Volume 7, Issue 3, pp. 133 - 139
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2015, Volume 113, Issue 7, pp. 1020 - 1026
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2019, Volume 25, Issue 14, pp. 4248 - 4254
Purpose: In phase I/II studies, nelipepimutS (NPS) plus GMCSF vaccine was well tolerated and effectively raised HER2specific immunity in patients with breast... 
IMMUNIZATION | HER2/NEU E75 VACCINE | GROUP-STUDY I-01 | THERAPY | TRASTUZUMAB | ONCOLOGY | GUIDELINES | IMMUNE-RELATED RESPONSE | HER-2/NEU | AMERICAN SOCIETY | PEPTIDE
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2015, Volume 16, Issue 2, pp. 421 - 425
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2015, Volume 16, Issue 17, pp. 7819 - 7824
Journal Article